Norgen researchers in our laboratory

A group of researchers from the Institute of Health Carlos III (ISCIII) in Spain, presented a poster at the annual meeting for the International Society of Extracellular Vesi

scientist looking through microscope

Currently, there is limited technology available for accurately predicting high-risk cancer biochemical recurrence (BCR).

artist rendering of Activated-Specialized Tissue Effector Cells and human heart

Cell therapy using cardiosphere-derived cells (CDCs) is an increasingly promising treatment for acute and congenital heart muscle injuries, including myocardial infarction (MI).

artist rendering of semi-transparent human covering face with back of hand with brain and skeleton visible.

The National Institute of Health estimates that approximately 6 in 100 000 individuals develop brain or central nervous system-related cancers each year1. Current approaches in the diagnosis of brain cancer include CT scans, MRI and tissue biopsy.

Artist rendering renal inflammatory pathway

RNA isolation and quantification of miRNAs are gaining significance as promising methods in cancer biomarker discovery.

Artist rendering mitochondrial DNA

Disease is defined as a state of disorder that lays the groundwork for conditions of ill health. Even the most complex disease begins with cellular imbalance, and scientists are looking to discover biomarkers that can detect the earliest signs of pathogenesis.